Evolving paradigms in valvular heart disease: where should guidelines move?
November 15, 2019 | 10.4244/EIJ-D-19-00818
Showing 1-20 of 61 articles
Interventions for valvular disease
Coronary sinus to mitral valve annulus topography and response to the percutaneous coronary sinus-based mitral valve contour system November 15, 2019 | 10.4244/EIJ-D-19-00054
Coronary interventions
Impact of Ticagrelor Monotherapy on Two-Year Clinical Outcomes in Patients with Long Stenting: A Post Hoc Analysis of the Global Leaders Trial September 10, 2019 | 10.4244/EIJ-D-19-00498
Interventions for valvular disease
Coronary Sinus to Mitral Valve Annulus Topography and Response to the Percutaneous Coronary Sinus-Based Mitral Valve Contour System July 2, 2019 | 10.4244/EIJ-D-19-00054
Coronary interventions
A Randomized, Intercontinental, Multicenter Study to Assess the Safety and Effectiveness of the Orsiro Sirolimus Eluting Stent in the Treatment of Subjects with de novo Coronary Artery Lesions BIOFLOW IV – Primary Outcome Target Vessel Failure at 12 Months. June 25, 2019 | 10.4244/EIJ-D-18-01214
Coronary interventions
Sustained safety and performance of the second-generation drug-eluting absorbable metal scaffold (DREAMS 2G) in patients with de novo coronary lesions: 3-year clinical results and angiographic findings of the BIOSOLVE-II first-in-man trial February 26, 2019 | 10.4244/EIJ-D-18-01000
Coronary interventions
Safety and performance of a resorbable magnesium scaffold under real-world conditions: 12-month outcomes of the first 400 patients enrolled in the BIOSOLVE-IV registry January 22, 2019 | 10.4244/EIJ-D-18-01058
Will ORBITA change my practice? ORBITA trial: Objective Randomised Blinded Investigation with optimal medical Therapy of Angioplasty in stable angina
October 19, 2018 | 10.4244/EIJY18M09_2
Stents and scaffolds
Preclinical evaluation of degradation kinetics and elemental mapping of first- and second-generation bioresorbable magnesium scaffolds October 12, 2018 | 10.4244/EIJ-D-17-00708
Welcome to PCR London Valves 2018: 10th Anniversary Edition
September 7, 2018 | 10.4244/EIJV14SABA1
Other
Evaluating the importance of sham-controlled trials in the investigation of medical devices in interventional cardiology August 24, 2018 | 10.4244/EIJ-D-18-00481
EAPCI Presidential “criss-cross”
May 20, 2018 | 10.4244/EIJV14I1A7
May in Paris! Join us! EuroPCR 2018
April 20, 2018 | 10.4244/EIJV13I17A326
Stents and scaffolds
Four-year follow-up of the randomised comparison between an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II Trial) January 19, 2018 | 10.4244/EIJ-D-17-00873
Report of an ESC-EAPCI Task Force on the evaluation and use of bioresorbable scaffolds for percutaneous coronary intervention: executive summary
January 19, 2018 | 10.4244/EIJ20170912-01
Answering the challenges of the New Year – the EAPCI in 2018
January 19, 2018 | 10.4244/EIJV13I13A243
The year of memories comes to an end, but the time of achievements continues
December 20, 2017 | 10.4244/EIJV13I11A201
Lesion preparation with cutting balloon angioplasty is associated with coronary aneurysm formation in polylactide bioresorbable vascular scaffold implantation
December 8, 2017 | 10.4244/EIJ-D-17-00375
PCR London Valves 2017: setting the standard in valvular heart disease treatment
November 20, 2017 | 10.4244/EIJV13I10A180
